Say-Barber-Biesecker-Young-Simpson (SBBYS) Variant of Ohdo Syndrome

The Say-Barber-Biesecker-Young-Simpson (SBBYS) variant is a rare genetic condition. It affects body development before birth and after birth. It is part of the KAT6B-related disorder spectrum. Changes (pathogenic variants) in the KAT6B gene cause this condition. The gene normally helps turn many other genes on and off during early development. When KAT6B does not work normally, several organs can develop differently. Children often have a distinctive face (mask-like look with narrow eye openings called blepharophimosis and droopy eyelids called ptosis), intellectual disability or developmental delay, hypotonia (low muscle tone), missing or small knee caps (patellae), and sometimes genital differences in boys. Some children also have congenital hypothyroidism, cleft palate, heart differences, and brain structure changes. The condition usually happens de novo (a new change in the child, not inherited from the parents), though very rarely it can be due to parental germline mosaicism. NCBI+2MedlinePlus+2

SBBYS is a rare genetic condition caused by pathogenic variants in the KAT6B gene, which encodes a histone acetyltransferase that helps turn other genes on or off during development. Children commonly have a characteristic “mask-like” facial appearance with blepharophimosis/ptosis, possible lacrimal (tear duct) anomalies, patellar (kneecap) hypoplasia or absence, hypotonia, global developmental delay/intellectual disability, and variable findings such as congenital heart defects, feeding difficulties, hearing loss, dental anomalies, cleft palate, hypothyroidism, and growth issues. Diagnosis is confirmed by finding a heterozygous pathogenic KAT6B variant, usually de novo (new in the child). Management focuses on early therapies and specialist care for each system involved. NCBI+2MedlinePlus+2

Other names

People and papers use a few names for the same condition. You may see:

• SBBYS variant of Ohdo syndrome or Ohdo syndrome, SBBYS type

• Say-Barber-Biesecker-Young-Simpson syndrome (spelled SBBYSS/SBBYS in older sources)

• Blepharophimosis-intellectual disability syndrome, SBBYS type (Orphanet naming)
  All of these refer to the same clinical picture linked to KAT6B. Orpha.net+1

Types

Doctors talk about KAT6B-related disorders as a spectrum. The two main “ends” of the spectrum are:

1. SBBYS variant of Ohdo syndrome — the focus of this guide; typically shows the mask-like face with blepharophimosis/ptosis, significant developmental delay, small or absent patellae, and sometimes hypothyroidism or cleft palate.

2. Genitopatellar syndrome (GPS) — also due to KAT6B; has overlapping features but tends to include flexion contractures, agenesis of the corpus callosum, kidney anomalies, and more severe skeletal findings.

Some children look intermediate between SBBYS and GPS. The exact KAT6B variant and where it is in the gene can influence the clinical picture. NCBI+2National Organization for Rare Disorders+2

---

Causes

Because this is a single-gene developmental disorder, “causes” mean how the gene change leads to features and what types of gene changes occur:

1. Pathogenic variant in KAT6B — the primary cause; it changes a histone acetyltransferase protein that controls gene activity during development. MedlinePlus+1

2. De novo origin — most variants are new in the child, not present in either parent. NCBI+1

3. Protein-truncating variants — many SBBYS variants truncate the protein, altering important tail regions that regulate other genes. PubMed+1

4. Variants clustered in late exons (e.g., exon 18) — several SBBYS changes sit in the gene’s later coding regions. MedlinePlus

5. Loss of normal histone acetylation — reduced or altered acetylation changes how tightly DNA is packaged and how genes turn on/off. MedlinePlus

6. Mis-regulation of developmental pathways — downstream genes that guide face, brain, thyroid, heart, and limb development are affected. PMC

7. Altered HOX and other patterning genes — KAT6B interacts with gene networks that set body plans; disruption can change craniofacial and limb patterning. PMC

8. Neurodevelopmental impact — abnormal gene expression during brain development can lead to intellectual disability and hypotonia. PMC

9. Skeletal development effects — changes affect patella formation and other skeletal elements. MedlinePlus

10. Craniofacial morphogenesis effects — cause the mask-like facies, blepharophimosis, and ptosis. PMC

11. Thyroid gland development effects — can result in congenital hypothyroidism. Orpha.net

12. Palate formation effects — increase the chance of cleft palate. MedlinePlus

13. Cardiac morphogenesis changes — raise the risk of congenital heart differences. NCBI

14. Genital development differences (especially in males) — undescended testes or other genital findings. MedlinePlus

15. Corpus callosum and midline brain development — some children have agenesis or thinning. NCBI

16. Feeding and airway development — hypotonia and craniofacial shape can make feeding and breathing harder in infancy. NCBI

17. Ocular surface and lacrimal system differences — tear gland issues and eyelid structure changes. MedlinePlus

18. Hearing development differences — middle ear or inner ear issues can occur. NCBI

19. Possible autism spectrum traits in some cases — rare reports suggest ASD can co-occur. PubMed

20. Parental germline mosaicism (rare) — explains recurrence in very rare families; parents test negative in blood but carry the variant in some egg/sperm cells. NCBI

---

Symptoms and signs

1. Distinctive face — a mask-like, less expressive face is common and helps doctors recognize the condition. MedlinePlus

2. Blepharophimosis — the eyelid openings are narrow, which can affect vision if severe. PMC

3. Ptosis — droopy upper eyelids may make children lift their chin or brows to see better. PMC

4. Developmental delay / intellectual disability — delays in motor, speech, and learning are frequent and vary in degree. NCBI

5. Hypotonia — low muscle tone makes infants feel “floppy” and can delay sitting or walking. PubMed

6. Missing or small kneecaps (patellae) — may affect kneeling, walking, or stability. MedlinePlus

7. Genital differences in males — like undescended testes; females usually have typical genitalia. MedlinePlus

8. Congenital hypothyroidism — low thyroid hormone at birth can worsen growth and development if untreated. Orpha.net

9. Cleft palate — can cause feeding and speech problems; may need surgery. MedlinePlus

10. Feeding difficulty and poor weight gain — due to hypotonia, palate differences, or reflux. NCBI

11. Heart differences — some have structural heart defects needing cardiology care. NCBI

12. Brain structure differences — such as agenesis or thinning of the corpus callosum in some children. NCBI

13. Vision issues — tear gland problems, ptosis, or refractive errors can affect sight. MedlinePlus

14. Hearing loss (variable) — may be conductive or sensorineural; needs testing. NCBI

15. Behavioral differences (rare reports of autism traits) — individual variation exists; supports like therapy can help. PubMed

---

Diagnostic tests

A. Physical examination 

1. General pediatric exam — checks growth, head size, and overall health; looks for the typical facial features that point toward SBBYS. MedlinePlus

2. Eye and eyelid exam — measures eyelid opening (blepharophimosis), checks for ptosis, and looks for tear-gland problems. PMC

3. Musculoskeletal exam — looks for small or missing patellae and joint laxity or contractures. MedlinePlus

4. Neurologic and developmental assessment — checks tone, reflexes, milestones, and learning needs. NCBI

5. ENT and oral exam — evaluates palate (for cleft or high arch), ear canals, and middle ear fluid that can affect hearing. MedlinePlus

B. “Manual” bedside tests / maneuvers 

6. Cover–uncover and Hirschberg tests — quick eye alignment checks for strabismus that may accompany eyelid issues. MedlinePlus

7. Upper eyelid lift test — simple clinical check of levator function to grade ptosis severity and plan surgery if needed. PMC

8. Patella palpation and knee tracking — clinician feels for patella size and movement to judge hypoplasia/agenesis. MedlinePlus

9. Oro-motor feeding assessment — bedside swallow observation to screen for poor suck, coordination, or aspiration risk. NCBI

10. Developmental screening tools (e.g., Ages & Stages) — quick, hands-on screens to map delays and guide early therapy. NCBI

C. Lab and pathological tests 

11. Newborn/serum thyroid function tests (TSH, free T4) — detect congenital hypothyroidism early so treatment can start promptly. Orpha.net

12. Genetic testing (molecular) — single-gene sequencing and deletion/duplication analysis of KAT6B, or broader panels/exome when features are unclear; confirms diagnosis. NCBI

13. Targeted parental testing — checks if the variant is de novo or inherited; informs recurrence risk. NCBI

14. Basic metabolic panel and CBC — baseline health checks; help prepare for anesthesia or surgery if needed. (General clinical practice.)

15. Endocrine profile (if indicated) — additional hormones if growth/puberty concerns appear. NCBI

16. Newborn screen review — confirms state screen results (thyroid and others) and flags anything missed. (General clinical practice.)

D. Electrodiagnostic tests 

17. Electrocardiogram (ECG) — screens heart rhythm in children with structural heart differences or before procedures. NCBI

18. Electroencephalogram (EEG) — if there are suspected seizures or unusual spells; some children with KAT6B variants can have neurologic events. NCBI

19. Polysomnography (sleep study) — if there are breathing pauses at night due to airway anatomy or hypotonia. (General pediatric indication.)

E. Imaging tests 

20. Echocardiogram — ultrasound of the heart to define any congenital heart difference. NCBI

21. Brain MRI — looks for corpus callosum differences and other brain findings linked to the syndrome. NCBI

22. Skeletal survey or targeted limb X-rays — documents patella size/absence and other bone findings. MedlinePlus

23. Renal ultrasound — screens kidneys and urinary system if clinically indicated, because genitourinary issues can occur in the spectrum. NCBI

Other helpful assessments tied to the tests above

• Formal audiology (ABR/OAE) — checks hearing early and supports speech-language planning. NCBI

• Formal ophthalmology — full eye exam to manage ptosis/blepharophimosis and protect vision. PMC

• Feeding/swallow study (videofluoroscopic) — if aspiration or severe feeding difficulty is suspected. (General pediatric indication.)

Non-pharmacological treatments (therapies & other care)

1. Early intervention (EI) & developmental therapies
   Start EI in infancy to promote motor, communication, cognitive, and adaptive skills. EI programs coordinate PT/OT/speech/feeding therapy and write goals the family can practice daily. Early, repetitive, play-based practice strengthens neural pathways and compensatory strategies, improving function over time. NCBI

2. Physical therapy (PT) for hypotonia & joint mobility
   PT uses stretching, positioning, and strengthening to counter hypotonia, prevent contractures/scoliosis, and build postural control for rolling, sitting, standing, and walking. Regular, gentle range-of-motion and bracing when needed help protect joints (including absent or small patellae) and promote safe movement patterns. NCBI

3. Orthopedic management & casting/bracing
   Orthopedists address contractures, clubfoot, hip/knee flexion issues, and spinal alignment. Serial casting and custom orthoses can gradually correct positions and stabilize joints; surgery is reserved for fixed deformities that impair function or cause pain. Goal: maximize comfort, mobility, and independence. NCBI

4. Occupational therapy (OT) for daily living
   OT builds hand use, feeding skills, dressing, and adapted play. Therapists introduce adaptive tools, seating, and splints to increase participation and reduce caregiver burden. Repetition and environmental modification let children succeed despite motor planning or tone differences. NCBI

5. Speech-language therapy (SLT) & augmentative communication
   SLT supports feeding/swallow and communication. If speech is delayed, AAC (signs, picture boards, speech-generating devices) gives a reliable voice early, reducing frustration and supporting language development while natural speech continues to evolve. NCBI

6. Feeding therapy & nutrition support
   For poor suck, reflux, or aspiration risk, feeding therapists and dietitians optimize textures, pacing, and positioning. When oral intake is insufficient or unsafe, temporary NG or longer-term G-tube feeding can ensure growth and medication delivery while therapy continues. NCBI

7. Cleft palate team care (if present)
   A craniofacial team coordinates timing of palate repair, ear/hearing checks, speech therapy, and dental/orthodontic care. Repair improves feeding, speech resonance, and reduces middle-ear problems. Team follow-up continues through growth. NCBI

8. Ophthalmology & eyelid/tear-duct care
   Regular eye exams address ptosis, blepharophimosis, tear-duct issues, refractive errors, and amblyopia. Patching, lubrication, or surgery may be used to protect the cornea and improve vision. Early treatment supports visual development and learning. NCBI

9. Audiology & hearing support
   Hearing loss is possible; newborn and periodic audiology enables early fitting of hearing aids or other devices. Consistent access to sound supports speech and brain development during critical windows. NCBI

10. Cardiology surveillance & congenital heart care
    Because congenital heart defects can occur, echocardiography and follow-up guide observation or repair. Good cardiac health improves energy for growth, therapy participation, and neurodevelopment. NCBI

11. Endocrine monitoring (thyroid, growth)
    Congenital hypothyroidism and growth issues may be present; regular thyroid and growth assessments ensure timely treatment and tracking of nutrition and puberty. Optimizing endocrine health supports brain and body development. Orpha.net+1

12. Dental/orthodontic care
    Dental anomalies and delayed eruption are reported. Early dental care, fluoride, and orthodontic evaluation help with chewing, speech clarity, and oral health, reducing pain and infection risks. NCBI

13. Gastroenterology support for reflux/constipation
    Positioning, thickened feeds, and toileting routines can ease reflux/constipation; specialists guide testing when symptoms persist, protecting lungs from aspiration and keeping nutrition on track. NCBI

14. Behavioral supports & family training
    Some children have sensory sensitivities or self-injury. Behavioral therapy focuses on communication, routines, and sensory strategies (noise/light control, deep-pressure input) to reduce distress and build coping. PubMed

15. Educational planning & special education
    An individualized education plan (IEP) sets realistic goals, accommodations, therapies, and assistive tech at school, providing structure and repetition over years of learning. NCBI

16. Genetic counseling for families
    Counselors explain autosomal dominant, usually de novo inheritance, recurrence risk, and options such as prenatal or preimplantation testing when the familial variant is known. NCBI

17. Social work & care coordination
    Linkage to services (transportation, equipment funding, respite) reduces caregiver stress and helps sustain the therapy schedule that drives progress. NCBI

18. Sleep hygiene
    Consistent routines, light control, and behavioral strategies can improve sleep, which enhances daytime learning, mood, and caregiver well-being. Medical evaluation is pursued if insomnia or apnea is suspected. NCBI

19. Safety planning & equipment
    Adaptive seating, bath chairs, walkers, or wheelchairs support safe mobility and participation while preventing falls and overuse injury in joints with patellar anomalies. NCBI

20. Regular surveillance schedule
    Annual checks track development, feeding, hearing, vision, thyroid, contractures/scoliosis, with cardiac/renal imaging as indicated. Surveillance finds issues early so they can be addressed promptly. NCBI

---

Drug treatments

There is no disease-modifying drug for SBBYS. Medications below treat specific problems that may occur in a given child; dosing is always individualized by the child’s clinicians. FDA labeling excerpts and references are provided.

1. Levothyroxine (L-T4) for hypothyroidism
   Class: Thyroid hormone. Purpose: Replace missing thyroid hormone to normalize growth and brain development. Mechanism: Synthetic T4 restores physiologic levels to correct low thyroid states. Dosage/Time: Weight-based; taken daily on an empty stomach; neonates/children require careful titration with TSH/T4 monitoring. Side effects: Overtreatment can cause tachycardia, irritability, poor weight gain; undertreatment risks developmental harm. FDA Access Data+1

2. Somatropin (recombinant human growth hormone) for proven GH deficiency
   Class: Pituitary hormone. Purpose: Improve linear growth and body composition when true GH deficiency coexists. Mechanism: Stimulates IGF-1 production and growth plates. Dosage/Time: Daily subcutaneous injections; dosing is weight-/IGF-1-guided. Side effects: Headache, edema, slipped capital femoral epiphysis, glucose effects; discontinue if neoplasm recurs. FDA Access Data+1

3. Levetiracetam for seizures
   Class: Antiepileptic. Purpose: Reduce seizure frequency across multiple seizure types. Mechanism: Modulates synaptic vesicle protein SV2A. Dosage/Time: Oral/IV; weight-based dosing, often BID; adjust for renal function. Side effects: Somnolence, behavioral changes, rare hypersensitivity/anaphylaxis. FDA Access Data+1

4. Topiramate for seizures
   Class: Antiepileptic. Purpose: Monotherapy or adjunct therapy for partial/generalized seizures. Mechanism: Enhances GABA, blocks AMPA/kainate, inhibits carbonic anhydrase. Dosage/Time: Start low and titrate; BID. Side effects: Cognitive slowing, weight loss, paresthesias; in pediatrics long-term use can affect growth parameters—monitor carefully. FDA Access Data+1

5. Valproate (valproic acid/valproate sodium) for seizures
   Class: Antiepileptic. Purpose: Broad-spectrum seizure control when benefits outweigh risks. Mechanism: Increases GABA, multiple ion-channel effects. Dosage/Time: Oral/IV, titrated to response; serum levels monitored. Side effects: Hepatotoxicity, pancreatitis, teratogenicity; use with caution and avoid in females who may become pregnant. FDA Access Data+1

6. Midazolam nasal spray (for seizure clusters)
   Class: Benzodiazepine. Purpose: Caregiver-administered rescue to stop clusters/status risk. Mechanism: GABA-A agonist causing rapid anticonvulsant effect. Dosage/Time: Single-dose nasal unit; dosing limits—no more than one episode every 3 days and five per month. Side effects: Sedation, respiratory depression; avoid in narrow-angle glaucoma. FDA Access Data+1

7. Baclofen (oral) for spasticity/rigid tone
   Class: GABA-B agonist antispasmodic. Purpose: Reduce muscle over-activity, ease care and comfort. Mechanism: Decreases excitatory neurotransmission in spinal cord. Dosage/Time: Titrate slowly to effect; watch for withdrawal if abruptly stopped. Side effects: Sedation, weakness, hypotonia; overdose can depress respiration. FDA Access Data+1

8. OnabotulinumtoxinA (BOTOX) for focal pediatric limb spasticity
   Class: Neuromuscular blocking toxin (local injection). Purpose: Temporarily relax overactive muscles to improve positioning, ease bracing, and reduce pain/care burden. Mechanism: Blocks presynaptic acetylcholine release. Dosage/Time: Inject every ~12 weeks to targeted muscles; used with therapy/orthoses. Side effects: Local weakness, dysphagia if spread; dose caps by weight. FDA Access Data

9. Glycopyrrolate oral solution (Cuvposa®) for problematic drooling
   Class: Anticholinergic. Purpose: Reduce sialorrhea that causes skin breakdown, aspiration risk, or social impact. Mechanism: Blocks muscarinic receptors to decrease saliva. Dosage/Time: Titrate by weight; monitor for anticholinergic effects. Side effects: Constipation, urinary retention, flushing, dry mouth, behavioral changes. FDA Access Data+1

10. Omeprazole for gastroesophageal reflux
    Class: Proton pump inhibitor. Purpose: Reduce acid exposure to treat GERD/esophagitis and protect airway during feeds. Mechanism: Irreversibly inhibits gastric H+/K+ ATPase. Dosage/Time: Once daily before meals; pediatric labeling exists for GERD/erosive esophagitis. Side effects: Headache, diarrhea; long-term use requires monitoring (e.g., magnesium). FDA Access Data+1

11. Levothyroxine (IV) when oral absorption is not possible
    Used short-term perioperatively or when severe hypothyroidism and no enteral route; carefully converted from oral dose and monitored. FDA Access Data

12. Somatropin (Norditropin®) alternative rhGH brand labeling for GH deficiency
    Brand specifics differ, but indications/mechanisms are equivalent to other rhGH products; clinicians select based on availability and patient factors. FDA Access Data

13. Rescue diazepam (alternative to midazolam) per clinician judgment
    Where appropriate, labeled rectal formulations may be used for acute repetitive seizures; choice depends on age, setting, and caregiver comfort. (FDA label not shown here to reduce redundancy.) FDA Access Data

14. Topical ophthalmic lubricants/antibiotics (as indicated)
    Used to protect the cornea with exposure from ptosis/blepharophimosis or to treat infections after tear-duct procedures; product choice individualized by ophthalmology. NCBI

15. Inhaled therapies (if co-existing airway disease)
    Some children have reactive airway disease; pediatric-labeled inhaled medications may be used per standard asthma care to support feeding/therapy tolerance. NCBI

16. Analgesics peri-orthopedic care
    Short courses to control pain around casting/surgeries enhance participation in rehabilitation; medication choice individualized. NCBI

17. Antibiotic prophylaxis when ENT/cardiac indications exist
    Follow pediatric cardiology/ENT guidelines where structural anomalies raise infection risks. NCBI

18. Constipation regimens
    Osmotic laxatives and stool softeners used per pediatric GI guidance to prevent painful stools and reflux exacerbation. NCBI

19. Antireflux adjuncts
    Short courses of acid suppression or prokinetics may be trialed under GI supervision when non-drug measures are insufficient. FDA Access Data

20. Peri-anesthesia planning meds
    Children with airway or cardiac anomalies need individualized anesthesia plans and peri-op medications; pre-op assessment is essential. NCBI

Important: Drug choices are symptom-based and must be prescribed and monitored by your child’s clinicians. The condition itself has no specific, approved disease-targeted drug today. NCBI

---

Dietary molecular supplements

1. Vitamin D — supports bone mineralization; monitor levels, especially with limited mobility or anticonvulsants that affect bone. NCBI

2. Calcium — paired with vitamin D for bone health in low-weight or low-mobility children; dosing individualized. NCBI

3. Iron — for iron-deficiency anemia from poor intake; improves energy/cognition when deficient; lab-guided. NCBI

4. Iodine (adequate dietary) — essential for thyroid hormone synthesis; ensure normal intake in hypothyroid care. NCBI

5. Omega-3 fatty acids — general support for cardiometabolic health; may aid triglycerides and are generally safe. NCBI

6. Multivitamin — fills gaps in selective eating; avoid megadoses; dietitian to individualize. NCBI

7. Fiber supplements — benefit constipation with hydration; titrate to avoid gas. NCBI

8. Probiotics (selected strains) — may help constipation/reflux symptoms in some children; quality varies; discuss GI first. NCBI

9. Thickening agents — for dysphagia/aspiration risk under SLP/GI plan; improves swallow safety. NCBI

10. Electrolyte oral rehydration — during illness to maintain hydration when feeds are borderline. NCBI

(Supplements do not replace medical therapy; use only if indicated and supervised.) NCBI

---

Immunity-booster / regenerative / stem-cell” concepts

There are no approved stem-cell or “regenerative” drugs that modify KAT6B gene function in SBBYS. Safe, proven steps are vaccination according to schedule, optimizing nutrition and sleep, and treating comorbidities that sap resilience (e.g., reflux, hypothyroidism). Experimental cell-based or gene-editing approaches are not standard of care for KAT6B-related disorders at this time and should only occur in IRB-approved clinical trials. NCBI

1. Routine childhood vaccines — best-evidence prevention of severe infection; schedule per national guidelines. NCBI

2. Seasonal influenza & COVID-19 vaccines (eligible ages) — reduce hospitalization risk that can derail feeding/therapies. NCBI

3. Nutrition optimization (dietitian-guided) — adequate protein, micronutrients, and growth monitoring support immune function. NCBI

4. Sleep regularization — improves immune signaling and daytime therapy performance. NCBI

5. Physical activity within ability — supports respiratory clearance and musculoskeletal health; guided by PT. NCBI

6. Clinical-trial awareness — families may explore registries or trials via genetics centers; outside of trials, no stem-cell/gene therapy is approved for SBBYS. NCBI

---

Surgeries

1. Cleft palate repair
   Closes palate to improve feeding, reduce nasal regurgitation/ear disease, and support normal speech resonance; usually timed in infancy/early toddler years by a craniofacial team. NCBI

2. Ophthalmic surgery (ptosis repair, tear-duct procedures)
   Elevates droopy lids that threaten vision and treats blocked ducts to prevent infections and tearing; improves visual development and comfort. NCBI

3. Orthopedic procedures (contracture release, tendon lengthening, foot corrections)
   Used when casting/therapy can’t maintain functional range, to improve positioning, bracing, comfort, and skin integrity; aids mobility and care. NCBI

4. Gastrostomy tube (G-tube)
   When oral intake is unsafe or inadequate, a G-tube secures calories/fluids/meds and reduces aspiration risk; often short- to medium-term while feeding skills mature. NCBI

5. Cardiac repairs (if defects present)
   Standard pediatric cardiac surgery or catheter interventions treat structural defects to optimize oxygenation, growth, and activity tolerance. NCBI

---

Preventions (practical, everyday)

1. Keep immunizations current.

2. Use hand hygiene and illness-exposure reduction.

3. Maintain safe feeding plans (textures/positions) to prevent aspiration.

4. Practice daily stretching/positioning and brace use to prevent contractures.

5. Schedule routine surveillance (hearing/vision/thyroid/orthopedics).

6. Ensure dental care and fluoride.

7. Use seatbelts/adaptive seating to prevent injury given tone and joint differences.

8. Create sleep routines to improve daytime functioning.

9. Plan caregiver training for transfers/feeding.

10. Maintain an emergency seizure plan if epilepsy is present. NCBI

---

When to see doctors (red flags)

See your care team urgently for breathing trouble, poor feeding/weight loss, recurrent choking or pneumonia, blue spells, new or worsening seizures, persistent vomiting or blood in stool, uncontrolled constipation, eye redness/pain or vision changes, severe sleepiness, fever with dehydration, or rapid regression of skills. For routine care, keep annual multidisciplinary visits covering development, nutrition/feeding, hearing, vision, endocrine (thyroid/growth), orthopedics/spine, and dental checks. NCBI

---

What to eat / what to avoid

Eat more of:

1. balanced meals with adequate protein;
2. dairy/fortified alternatives for calcium/vitamin D;
3. fruits/vegetables for fiber and micronutrients;
4. whole grains/added fiber for constipation prevention;
5. healthy oils (omega-3 sources).

Avoid/limit:

1. choking-risk textures unless cleared by SLP;
2. highly acidic/spicy foods if reflux flares;
3. excess sugar that displaces nutrition;
4. very low-fiber patterns that worsen constipation;
5. megadose supplements without clinician guidance. Dietitians align choices with growth and swallow safety plans. NCBI

---

Frequently asked questions

1. Is SBBYS inherited?
   Usually autosomal dominant, de novo—not inherited from parents; recurrence risk is typically low but not zero due to possible mosaicism; ask genetics about testing options. NCBI

2. How is it diagnosed?
   By finding a pathogenic KAT6B variant via gene panel or exome/genome sequencing in a child with suggestive features. NCBI

3. Is there a cure?
   No specific cure today; outcomes improve with early, coordinated therapies and treating each medical issue as it arises. NCBI

4. Will my child walk/talk?
   Abilities vary widely. Many children make progress with PT/OT/SLT, AAC, orthopedic care, and medical management tailored to their needs. NCBI

5. Are seizures required for diagnosis?
   No—some children have seizures, others do not. If present, standard epilepsy medicines and rescue plans are used. NCBI

6. What about growth and hormones?
   Thyroid and growth should be checked regularly; treat hypothyroidism and true GH deficiency per pediatric endocrine guidance. Orpha.net

7. Can eye problems be fixed?
   Yes—glasses, patching, lubrication, and sometimes surgery protect the eye and improve vision; early ophthalmology is key. NCBI

8. Are feeding problems common?
   Yes; feeding therapy, nutrition plans, reflux management, and—if needed—G-tubes support safe growth and medication delivery. NCBI

9. What about teeth?
   Dental anomalies and delayed eruption occur; early dental care and orthodontics help chewing, speech, and health. NCBI

10. Will school help?
    Yes—IEPs with therapies and assistive tech support learning, communication, and participation. NCBI

11. Is there a patient community?
    Rare-disease organizations and KAT6A/6B family groups can help with shared experience and practical tips. National Organization for Rare Disorders+1

12. What research is happening?
    Ongoing studies map the KAT6B spectrum and genotype-phenotype links; novel variants continue to be reported. GIM Journal+2PubMed+2

13. Could my next child be affected?
    Risk is generally low but not zero; genetics can discuss recurrence, parental mosaicism, and reproductive options. NCBI

14. Does SBBYS overlap with genitopatellar syndrome?
    Yes—both are KAT6B disorders on a clinical spectrum with overlapping features. NCBI

15. Where can I read a clinician-level overview?
    See GeneReviews (KAT6B Disorders) for detailed diagnostic, management, and surveillance guidance used by clinicians. NCBI

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 28, 2025.